Eventide Asset Management - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 83 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q1 2020$2,033,000
-45.2%
270,0000.0%0.07%
-37.1%
Q4 2019$3,713,000
+15.7%
270,0000.0%0.10%
-0.9%
Q3 2019$3,208,000
-15.1%
270,0000.0%0.11%
-7.8%
Q2 2019$3,777,000
-21.8%
270,0000.0%0.12%
-30.7%
Q1 2019$4,828,000
+13.7%
270,0000.0%0.17%
-11.7%
Q4 2018$4,247,000270,0000.19%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders